---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-119817"
form_type: "8-K"
ticker: "TELA"
cik: "0001561921"
company_name: "TELA Bio, Inc."
filed_at: "2021-09-27T23:59:59+00:00"
generated_at: "2026-06-29T01:16:21.206647+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# TELA Bio appoints Roberto Cuca as CFO and COO effective September 27, 2021

## Summary
- Roberto Cuca appointed CFO and COO, effective 9/27/21; succeeds Megan Smeykal as principal financial officer.
- Employment agreement: $425k base salary, 50% target bonus, and inducement option for 144k shares at $13.31.
- Option vests 25% on 1st anniversary, 75% over 36 months; severance includes 9-12 months base salary.
- Cuca previously CFO of OraSure Technologies (Jun 2018-Sep 2021) and Trevena (Sep 2013-May 2018).
- Inducement grant complies with Nasdaq Rule 5635(c)(4).

## SEC filing metadata
- accession: 0001104659-21-119817
- form_type: 8-K
- ticker: TELA
- cik: 0001561921
- company_name: TELA Bio, Inc.
- filed_at: 2021-09-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1561921/000110465921119817/0001104659-21-119817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1561921/000110465921119817/tm2128539d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-119817
- JSON: https://secwatch.observer/filing/0001104659-21-119817.json
- Plain text: https://secwatch.observer/filing/0001104659-21-119817.txt

## Key facts
- Executive change
  Megan Smeykal changed role as Vice President – Corporate Controller at TELA Bio, Inc..
  - Action: will cease performing the duties
  - Role: Vice President – Corporate Controller
  source text: Effective upon Mr. Cuca’s employment, Megan Smeykal, the Company’s Vice President – Corporate Controller, will cease performing the duties of the principal financial officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1561921/000110465921119817/0001104659-21-119817-index.htm
- Executive change
  Roberto Cuca was appointed as Chief Financial Officer and Chief Operating Officer at TELA Bio, Inc..
  - Action: appointed
  - Role: Chief Financial Officer and Chief Operating Officer
  source text: announced the appointment of Roberto Cuca as Chief Financial Officer and Chief Operating Officer of the Company, effective September 27, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1561921/000110465921119817/0001104659-21-119817-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.